Controlled delivery of VEGF via modulation of alginate microparticle ionic crosslinking

被引:144
作者
Jay, Steven M. [1 ]
Saltzman, W. Mark [1 ]
机构
[1] Yale Univ, Dept Biomed Engn, Interdept Program Vasc Biol & Therapeut, New Haven, CT 06511 USA
关键词
VEGF; Protein drug delivery; Therapeutic angiogenesis; Controlled release; Microparticles; ENDOTHELIAL GROWTH-FACTOR; PERIPHERAL ARTERIAL-DISEASE; IMMUNOISOLATED TRANSPLANTATION; EMULSIFICATION/INTERNAL GELATION; THERAPEUTIC ANGIOGENESIS; ENHANCES ANGIOGENESIS; SUSTAINED DELIVERY; CONTROLLED-RELEASE; MICROSPHERES; BEADS;
D O I
10.1016/j.jconrel.2008.10.019
中图分类号
O6 [化学];
学科分类号
070301 [无机化学];
摘要
Clinical application of therapeutic angiogenesis is hampered by a lack of viable systems that demonstrate controlled, sustained release of vascular endothelial growth factor (VEGF). Alginate has emerged as a popular material for VEGF delivery; however most alginate-based systems offer limited means to control the rate of VEGF release beyond reducing the VEGF:alginate ratio to suboptimal efficiency. This study describes methods to control the release of VEGF from small (<10 pm mean diameter) alginate microparticles via the use of different ionic crosslinkers. Crosslinking with Zn2+ versus Ca2+ reduced VEGF diffusional release and the combination of discrete populations of either Zn2+ or Ca2+-crosslinked particles allowed for control over the sustained release profiles for VEGF. The particle preparations were non-toxic and VEGF was bioactive after release. These results demonstrate that ionic modulation of alginate crosslinking is a viable strategy for controlling release of VEGF while retaining the high protein:polymer ratio that makes alginate an attractive carrier for delivery of protein therapeutics. (c) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:26 / 34
页数:9
相关论文
共 57 条
[1]
Studies on diffusion in alginate gels .1. Effect of cross-linking with calcium or zinc ions on diffusion of acetaminophen [J].
Aslani, P ;
Kennedy, RA .
JOURNAL OF CONTROLLED RELEASE, 1996, 42 (01) :75-82
[2]
Baumgartner I, 1998, VASA-J VASCULAR DIS, V27, P201
[3]
Essentiality, toxicology and chelation therapy of zinc and copper [J].
Cai, L ;
Li, XK ;
Song, Y ;
Cherian, MG .
CURRENT MEDICINAL CHEMISTRY, 2005, 12 (23) :2753-2763
[4]
Cross-linking mechanisms of calcium and zinc in production of alginate microspheres [J].
Chan, LW ;
Jin, Y ;
Heng, PWS .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 242 (1-2) :255-258
[5]
Development of poly-(D,L-lactide-coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis [J].
Cleland, JL ;
Duenas, ET ;
Park, A ;
Daugherty, A ;
Kahn, J ;
Kowalski, J ;
Cuthbertson, A .
JOURNAL OF CONTROLLED RELEASE, 2001, 72 (1-3) :13-24
[6]
Encapsulation of RIN-m5F cells within Ba2+ cross-linked alginate beads affects proliferation and insulin secretion [J].
Cui, Yu-Xin ;
Shakesheff, Kevin M. ;
Adams, Gary .
JOURNAL OF MICROENCAPSULATION, 2006, 23 (06) :663-676
[7]
Polymer relationships during preparation of chitosan-alginate and poly-l-lysine-alginate nanospheres [J].
De, SJ ;
Robinson, D .
JOURNAL OF CONTROLLED RELEASE, 2003, 89 (01) :101-112
[8]
Extensive in vivo angiogenesis following controlled release of human vascular endothelial cell growth factor:: Implications for tissue engineering and wound healing [J].
Elçin, YM ;
Dixit, V ;
Gitnick, T .
ARTIFICIAL ORGANS, 2001, 25 (07) :558-565
[9]
A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans [J].
Eppler, SM ;
Combs, DL ;
Henry, TD ;
Lopez, JJ ;
Ellis, SG ;
Yi, JH ;
Annex, BH ;
McCluskey, ER ;
Zioncheck, TF .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (01) :20-32
[10]
In vitro release of vascular endothelial growth factor from gadolinium-doped biodegradable microspheres [J].
Faranesh, AZ ;
Nastley, MT ;
de la Cruz, CP ;
Haller, MF ;
Laquerriere, P ;
Leong, KW ;
McVeigh, ER .
MAGNETIC RESONANCE IN MEDICINE, 2004, 51 (06) :1265-1271